dc.contributor.author | Braley, Tiffany J. | |
dc.contributor.author | Whibley, Daniel | |
dc.contributor.author | Alschuler, Kevin N | |
dc.contributor.author | Ehde, Dawn | |
dc.contributor.author | Chervin, Ronald D | |
dc.contributor.author | Clauw, Daniel J. | |
dc.contributor.author | Williams, David | |
dc.contributor.author | Kratz, Anna L. | |
dc.date.accessioned | 2020-11-24T15:34:01Z | |
dc.date.available | 2020-11-24T15:34:01Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Braley , T J , Whibley , D , Alschuler , K N , Ehde , D , Chervin , R D , Clauw , D J , Williams , D & Kratz , A L 2020 , ' Cannabinoid use among Americans with MS : Current trends and gaps in knowledge ' , Multiple sclerosis journal , vol. 6 , no. 3 , pp. 1-12 . https://doi.org/10.1177/2055217320959816 | en |
dc.identifier.issn | 1352-4585 | |
dc.identifier.other | PURE: 180304723 | |
dc.identifier.other | PURE UUID: 0b05b374-260d-45ba-860d-4c682a02f9a7 | |
dc.identifier.other | PubMedCentral: PMC7518014 | |
dc.identifier.other | PubMed: 33014410 | |
dc.identifier.other | SCOPUS: 85101595843 | |
dc.identifier.other | Scopus: 85101595843 | |
dc.identifier.uri | https://hdl.handle.net/2164/15405 | |
dc.description | Acknowledgements: The National Multiple Sclerosis Society (NMSS) provided participant recruitment support. The Michigan Institute for Clinical & Health Research (MICHR:NIH award number UL1TR002240) provided participant recruitment support through UMHealthResearch.org. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or NMSS. The investigators thank Shubha Kulkarni for her assistance with data collection. | en |
dc.format.extent | 12 | |
dc.language.iso | eng | |
dc.relation.ispartof | Multiple sclerosis journal | en |
dc.rights | Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). | en |
dc.subject | Multiple sclerosis | en |
dc.subject | cannabinoids | en |
dc.subject | cannabis | en |
dc.subject | pain | en |
dc.subject | insomnia | en |
dc.subject | sleep disturbance | en |
dc.subject | R Medicine | en |
dc.subject | Clinical Neurology | en |
dc.subject | Neurology | en |
dc.subject.lcc | R | en |
dc.title | Cannabinoid use among Americans with MS : Current trends and gaps in knowledge | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1177/2055217320959816 | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=0034021266&partnerID=8YFLogxK | en |
dc.identifier.vol | 6 | en |
dc.identifier.iss | 3 | en |